Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,038,169
-$812,090 QoQ
Shares Held
547,935
-18.3% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 257 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,275,458 across 201 Biotechnology names. ERAS ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ERAS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,038,169 | 547,935 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,850,259 | 670,597 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $154,157 | 112,524 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $139,518 | 55,585 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $57,133 | 20,928 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $410,175 | 173,803 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $104,815 | 49,209 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $89,719 | 32,507 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,626 | 10,175 | Shares | Defined | 2023-05-22 | |
| No filing history on record for this holder in this stock. | ||||||